Edition:
United States

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.44USD
12:27pm EDT
Change (% chg)

$0.05 (+3.60%)
Prev Close
$1.39
Open
$1.38
Day's High
$1.44
Day's Low
$1.38
Volume
4,221
Avg. Vol
12,253
52-wk High
$2.25
52-wk Low
$1.29

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.17 December 18 Oct 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 0 0
(2) OUTPERFORM 2 2 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.00 0.00 0.00 --
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.67 2.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 3 -0.17 -0.13 -0.21 --
Quarter Ending Mar-19 1 -0.16 -0.16 -0.16 --
Year Ending Dec-18 3 -0.61 -0.55 -0.66 --
Year Ending Dec-19 3 -0.65 -0.37 -0.91 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.20 0.28 0.07 35.12
Quarter Ending Sep-16 0.42 0.20 0.22 51.65
Quarter Ending Dec-15 0.51 0.42 0.08 16.54

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 0.00 0.00 0.00 0.00 --
Quarter Ending Mar-19 0.00 0.00 0.00 -- --
Year Ending Dec-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-19 0.67 0.67 0.67 0.00 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 0 0 0
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings